Suppr超能文献

抗体依赖性淋巴细胞毒性:效应细胞与靶细胞相互作用的分析。

Antibody-dependent lymphocytotoxicity: an analysis of effector cell-target cell interactions.

作者信息

van Oers M H, de Goede R E, Zeijlemaker W P

出版信息

J Immunol. 1978 Aug;121(2):499-504.

PMID:98585
Abstract

Antibody-dependent lymphocytotoxicity (ADL) was studied with human peripheral blood lymphocytes as effector cells and P815 mouse mastocytoma cells, sensitized with rabbit IgG antibodies, as target cells. Enzyme-substrate-like kinetics were used to describe ADL inhibition induced by two types of inhibitors. Human IgG, both native and heat-aggregated, proved to be a competitive inhibitor of ADL at the target cell level. Human peripheral blood monocytes inhibited ADL in an apparently irreversible fashion, without appreciable evidence for competition. The data obtained provide strong support for the validity of an enzyme-substrate-like mechanism of ADL. Moreover, our results indicate that in order to measure the lytic capacity properly, cell populations, well defined as to their composition, should be used. In the second part of the study, it was investigated whether the two types of cells capable of lysing sensitized target cells, i.e., null cells and T cells, differed with respect to their affinity for the target cells. Application of enzyme-like kinetics revealed considerable differences in maximal killing rate between the two subsets of K cells. However, the parameter related to the affinity toward the target cells was found to be of the same magnitude for the two types of effector cells.

摘要

以人外周血淋巴细胞作为效应细胞,用兔IgG抗体致敏的P815小鼠肥大细胞瘤细胞作为靶细胞,研究了抗体依赖性淋巴细胞毒性(ADL)。采用类似酶-底物的动力学来描述两种抑制剂诱导的ADL抑制作用。天然和热聚集的人IgG在靶细胞水平上被证明是ADL的竞争性抑制剂。人外周血单核细胞以明显不可逆的方式抑制ADL,没有明显的竞争证据。获得的数据为ADL类似酶-底物机制的有效性提供了有力支持。此外,我们的结果表明,为了正确测量裂解能力,应该使用成分明确的细胞群体。在研究的第二部分,研究了两种能够裂解致敏靶细胞的细胞类型,即无颗粒细胞和T细胞,对靶细胞的亲和力是否存在差异。应用类似酶的动力学揭示了K细胞两个亚群之间最大杀伤率的显著差异。然而,发现与对靶细胞亲和力相关的参数对于两种效应细胞类型来说大小相同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验